We are monitoring the impact of COVID-19 on APAC Antivenom Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1504
Share on
Share on

Asia Pacific Antivenom Market Research Report – Segmented By Type, Animal and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019 - 2024)

Pulished: February, 2020
ID: 1504
Pages: 145

The size of the Asia-Pacific Antivenom Market is expected to reach USD 0.51 billion by 2024 from USD 0.37 billion in 2019, growing at a CAGR of 8.59% during the forecast period 2019 - 2024.

Antivenom is described as the biological product that detoxifies the poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that approximately 40,000-80,000 people die in Asia (Majorly from India) with snakebites annually. To overcome poisonous effects after venomous bites the manufacturers developed a number of Antivenom products including vaccines and hyperimmune sera.

Rising demand for antivenom products, a growing number of snakebite cases as compared to developed regions, development of effective antivenom products against more number of snake species, and the increasing number of manufacturers to focus on antivenom products in the Asia region (especially in India) are driving the growth of Asia-Pacific Antivenom Market.

However, a dearth of antivenom products, the high cost of the products, the existence of new regulations, the requirement of training to medical staffs, and presence of underdeveloped medical infrastructure are restraining the growth of the Asia-Pacific Antivenom Market.

This research report is segmented & sub-segmented the market into the following categories:

  • By Type: Vaccines and Hyperimmune Sera (Homologous and Heterologous)
  • By Animal: Snakes, Scorpions, Spiders and Others
  • By Country: India, China, Japan, South Korea,  Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Regionally, The Asia-Pacific Anti-poison market is predicted to hold the largest market share in the forecast period. This is due to advances in medicine and huge patient pools, as well as the high incidence of snake bites in countries like India and Bangladesh. The data published in 2017 by the Journal of the Association of Physicians of India reported that about 50,000 people are infected annually due to snake bite. India is a religious region in Asia-Pacific and respects the snake according to their tradition.

In rural areas, adoption rates for poison are very low as traditional treatment methods are still in use. In Bangladesh, only 3% of snakebite victims visit hospitals for treatment which is published in June 2018 by the Journal of Pharmacology & Clinical Toxicology. Public and private organizations work together to raise awareness of poisonous bites in animals and the use of antidotes.

Leading companies in the APAC Antivenom Market are Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh) and Bharat Serum.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Vaccines  

                                5.1.3 Hyperimmune Sera             

                                                5.1.3.1 Homologous

                                                5.1.3.2 Heterologous

                                5.1.4 Y-o-Y Growth Analysis, By type       

                                5.1.5 Market Attractiveness Analysis, By Type     

                                5.1.6 Market Share Analysis, By Type      

                5.2 Animal                          

                                5.2.1 Introduction           

                                5.2.2 Snakes      

                                5.2.3 Scorpions

                                5.2.4 Spiders     

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By Animal  

                                5.2.7 Market Attractiveness Analysis, By Animal

                                5.2.8 Market Share Analysis, By Animal 

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.2 By Animal

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.2 By Animal

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.2 By Animal

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Instituto Bioclon, S.A. de C.V.                              

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer AG                     

                8.3 CSL Limited                 

                8.4 Roche                           

                8.5 Merck & Co                

                8.6 Rare Disease Therapeutics, Inc.                         

                8.7 Vins Bioproducts Limited                      

                8.8 BTG Plc                         

                8.9 Incepta Vaccine Ltd                 

                8.10 Bharat Serim and Vaccines Limited (BSV)                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  2. Asia-Pacific Vaccines Market By Region, From 2019 - 2024 ( USD Million )
  3. Asia-Pacific Hyperimmune Sera Market By Region, From 2019 - 2024 ( USD Million )
  4. Asia-Pacific Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  5. Asia-Pacific Snakes Market By Region, From 2019 - 2024 ( USD Million )
  6. Asia-Pacific Scorpions Market By Region, From 2019 - 2024 ( USD Million )
  7. Asia-Pacific Spiders Market By Region, From 2019 - 2024 ( USD Million )
  8. Asia-Pacific Others Market By Region, From 2019 - 2024 ( USD Million )
  9. Japan Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  10. Japan Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  11. China Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  12. China Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  13. India Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  14. India Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  15. Australia Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  16. Australia Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  17. South Korea Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  18. South Korea Antivenom Market By Animal, From 2019 - 2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample